Rob Bettigole, Elm Street Ventures

Judge, Northeast (Yale) Regional Finals
LinkedIn

 

Rob is the founder and Managing Partner of Elm Street Ventures. Rob serves as Chairman of P2 Science and Samara Innovations, and is Chairman & CEO of Occam Sciences. He is a board member of AxioMx, Inc., serves as an observer on the BioRelix board, and served as an observer on the boards of Affomix Corporation and Metagenomix. Mr. Bettigole’s venture capital experience was gained at Rothschild Ventures and Investor AB, where his investments included Maxim Integrated Products, Gensia Pharmaceuticals, and Microgenics Corporation. Subsequently, he helped found Surety Technologies, Inc., a spin out from Bellcore, and Alexion (NASDAQ: ALXN), with researchers from the Yale Medical School. Before founding Elm Street, Mr. Bettigole was president of a business that held patents on and marketed a product for bridge construction and rehabilitation, which he successfully developed and sold. Mr. Bettigole has a BS in Engineering and Applied Science from Yale University and an MPPM from the Yale School of Management, where he is an Entrepreneur-in-Residence. He is a Licensed Professional Engineer and holds several U.S. and foreign patents. Mr. Bettigole has served on the Operating Board of the Yale Entrepreneurial Institute since its founding in 2007.

2014-11-12T14:47:45+00:002015, 2015 Northeast (Yale), Judge|